SBIR/STTR Research Award
Innovative oral regenerative therapy leveraging immunoregenerative mechanisms.
Award amount
$361,499Program and phase
STTR · Phase IAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ORIDIVUS LLC
- Proposal award date
- 2024-07-16
- Contract end date
- 2025-07-15
- UEI
- YF5VPLV33MU9
- Solicitation number
- PA25-212
- Topic code
- NIDCR
Research abstract
This supplement will support Oridivus, LLC to participate as part of the I-Corps program, focused on developing our business model canvas to assess the gaps in our approach to the oral wound healing market. During the I-Corps program we will perform over 100 interviews identifying the key stakeholders in the oral wound healing environment including dentists, oral surgeons, periodontists, and otolaryngologists along with the specific user needs of each different speciality. At the conclusion of the I-Corps program we will have identified the beach head market, a plan to address an unmet need in the market and continued to refine our business model canvas based on our ongoing customer and ecosystem discovery.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- RegendoGEL for guided pulp and dentin regeneration
- CraniaMap: Joint Solution for Auto-Segmentation and Landmarking from CBCT Scans
- Improving Caries Diagnosis with Targeted Nanoparticle-Enhanced AI-Assisted Intraoral Imaging
- Epigenetic Compounds Stimulating Dental Bone Repair
- AI-linked cytomics-on-a-chip to enable near-real time identification and management of oral lichenoid lesions in primary care